Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. S.F. Oosting

Publicaties

Identification of new head and neck squamous cell carcinoma molecular imaging targets

Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement

Nasopharyngeal carcinoma: nationwide trends in subtype-specific incidence and survival over 3 decades in a non-endemic area

Oncological and functional outcomes in T3 and T4 laryngeal cancer patients: choice for larynx preservation or total laryngectomy based on expected laryngeal function

[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to predict watchful waiting duration in patients with metastatic clear cell renal cell carcinoma

Abstract 5611: LAG-3 PET imaging in patients with cancer before immune checkpoint inhibitor therapy

ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0

Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit

Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful Waiting

Lees meer

Pers/media

Checklist Aims to Boost Quality of Life in Clinical Trials

Novel checklist for Quality of Life to bring ESMO-MCBS and clinical trials to the next level

Podcast over hoofd-hals-tumoren

Vaccino Covid: nei pazienti in chemioterapia buona risposta anticorpale

COVID-19 vaccination safe, effective during treatment for solid tumors

Lees meer